- Supported exchanges /
- ST /
- CYXO.ST
Cyxone AB (CYXO ST) stock market data APIs
kr-0.2365
-0.27(-915.3%)
as of November 21, 2024
Price chart is built with Anychart
Cyxone AB (publ), a clinical stage biotech company, develops disease modifying therapies for autoimmune and autoinflammatory diseases. Its product pipeline comprises Rabeximod, which is in phase II clinical development for the treatment of rheumatoid arthritis; and T20K for the treatment of multiple sclerosis and is in phase I trial. The company was founded in 2015 and is headquartered in Malmö, Sweden.
Cyxone AB Financial Data Overview
| -0.2505 | |
| -0.2365 | |
| - | |
| 0.38 | |
| -0.243 | |
| 0.01-0.1646 | |
| 11 064 K | |
| 375 M | |
| 3 518 K | |
| 0.424 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'CYXO',
Type:
'Common Stock',
Name:
'Cyxone AB',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
'SE0007815428',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Cyxone AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 518 K
- EBITDA -18 977 000
- Earnings Per Share -0.14
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cyxone AB Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get Cyxone AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
